Logo image of GRO

BRAZIL POTASH CORP (GRO) Stock Fundamental Analysis

USA - NYSEARCA:GRO - CA10586A1084 - Common Stock

2.66 USD
-0.1 (-3.62%)
Last: 9/23/2025, 8:04:02 PM
2.66 USD
0 (0%)
After Hours: 9/23/2025, 8:04:02 PM
Fundamental Rating

2

Taking everything into account, GRO scores 2 out of 10 in our fundamental rating. GRO was compared to 83 industry peers in the Chemicals industry. GRO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GRO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GRO had negative earnings in the past year.
In the past year GRO has reported a negative cash flow from operations.
GRO Yearly Net Income VS EBIT VS OCF VS FCFGRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

GRO has a Return On Assets of -44.09%. This is amonst the worse of the industry: GRO underperforms 91.57% of its industry peers.
GRO has a worse Return On Equity (-45.91%) than 81.93% of its industry peers.
Industry RankSector Rank
ROA -44.09%
ROE -45.91%
ROIC N/A
ROA(3y)-22.43%
ROA(5y)N/A
ROE(3y)-23.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GRO Yearly ROA, ROE, ROICGRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

GRO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GRO Yearly Profit, Operating, Gross MarginsGRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

GRO has less shares outstanding than it did 1 year ago.
GRO has a worse debt/assets ratio than last year.
GRO Yearly Shares OutstandingGRO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
GRO Yearly Total Debt VS Total AssetsGRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M

2.2 Solvency

GRO has an Altman-Z score of 9.27. This indicates that GRO is financially healthy and has little risk of bankruptcy at the moment.
GRO has a Altman-Z score of 9.27. This is amongst the best in the industry. GRO outperforms 97.59% of its industry peers.
GRO has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
GRO has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. GRO outperforms 97.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.27
ROIC/WACCN/A
WACCN/A
GRO Yearly LT Debt VS Equity VS FCFGRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 5.43 indicates that GRO has no problem at all paying its short term obligations.
The Current ratio of GRO (5.43) is better than 95.18% of its industry peers.
GRO has a Quick Ratio of 5.43. This indicates that GRO is financially healthy and has no problem in meeting its short term obligations.
GRO's Quick ratio of 5.43 is amongst the best of the industry. GRO outperforms 95.18% of its industry peers.
Industry RankSector Rank
Current Ratio 5.43
Quick Ratio 5.43
GRO Yearly Current Assets VS Current LiabilitesGRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

GRO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -294.90%.
EPS 1Y (TTM)-294.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1238.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 31.93% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y75.63%
EPS Next 2Y31.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GRO Yearly EPS VS EstimatesGRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.1 -0.2 -0.3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

GRO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GRO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GRO Price Earnings VS Forward Price EarningsGRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GRO Per share dataGRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as GRO's earnings are expected to grow with 31.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.93%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GRO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRAZIL POTASH CORP

NYSEARCA:GRO (9/23/2025, 8:04:02 PM)

After market: 2.66 0 (0%)

2.66

-0.1 (-3.62%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)N/A N/A
Inst Owners1.74%
Inst Owner Change58.59%
Ins Owners6.73%
Ins Owner ChangeN/A
Market Cap107.01M
Analysts80
Price Target3.83 (43.98%)
Short Float %0.63%
Short Ratio0.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-31.82%
PT rev (3m)-31.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.78
P/tB 0.78
EV/EBITDA N/A
EPS(TTM)-2
EYN/A
EPS(NY)-0.33
Fwd EYN/A
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.37
OCFYN/A
SpS0
BVpS3.43
TBVpS3.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -44.09%
ROE -45.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-22.43%
ROA(5y)N/A
ROE(3y)-23.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.43
Quick Ratio 5.43
Altman-Z 9.27
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-294.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1238.27%
EPS Next Y75.63%
EPS Next 2Y31.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-249.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year74.02%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-24.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.56%
OCF growth 3YN/A
OCF growth 5YN/A